Pharma 3.0: Meeting the challenge
Thought Center Webcasts on-demand Pharma 3.0 is rapidly taking shape. This new health ecosystem promises improved health outcomes for patients, new partnerships with non-traditional players and economic benefits for health care systems. To create the new business models that will redefine the industry, a new customer-focused strategy is needed.
Carolyn Buck Luce, Ernst & Young's Global Life Sciences Market Leader, and a panel of industry leaders discuss the emerging transformational strategies and key questions, such as:
- What do life sciences companies need to do to adapt their strategies for success in 3.0?
- What are the skills and organizational capabilities needed to participate in disruptive new business models?
- How do you go about implementing the changes that will be needed?
- What can life sciences companies learn from other industries?
Watch the one-minute recap from our recent Webcast: Pharma 3.0 - Meeting the Challenge
Listen to Bill Crown. President, OptumInsight, discuss the latest shifts in the health care ecosystem. Can your life sciences company improve its communications with payers and practitioners?
/$FILE/13L00002.jpg)
